Skip to main
VNDA
VNDA logo

Vanda Pharmaceuticals (VNDA) P/E Ratio

P/E Ratio as of Jun 13, 2025: -5.96

Average-5.83
Median-5.80
Minimum-6.15
Maximum-5.49
-5.96
Past Month-0.77 (14.84%)
The P/E ratio for Vanda Pharmaceuticals (VNDA) is -5.96 as of Jun 13, 2025. This represents a decrease of -67.02% compared to its 12-month average P/E ratio of -18.07. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Vanda Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Vanda Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vanda Pharmaceuticals to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Vanda Pharmaceuticals (VNDA) P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$4.30-5.68
May 1, 2025$4.44-13.66
Apr 1, 2025$4.50-13.85
Mar 3, 2025$4.72-14.52
Feb 3, 2025$4.31-15.26
Jan 2, 2025$4.82-17.06

Vanda Pharmaceuticals (VNDA) End of Year P/E Ratio

DateP/E ratioChange
2025-5.96-64.86%
2024-16.96-182.53%
202320.55-68.91%
202266.10+145.45%
202126.93-13.49%
202031.13

FAQs About Vanda Pharmaceuticals (VNDA) P/E ratio

The latest P/E ratio of Vanda Pharmaceuticals (VNDA) is -5.96, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Vanda Pharmaceuticals’s last 12-month average P/E ratio is -18.07, compared to its current P/E ratio of -5.96. This reflects a decrease of -67.02%.

Vanda Pharmaceuticals’s current P/E ratio of -5.96 is lower than its last 12-month average P/E of -18.07. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Vanda Pharmaceuticals’s average P/E ratio over the last 3 years is 21.14. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Vanda Pharmaceuticals’s average P/E ratio over the last 5 years is 23.82. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Vanda Pharmaceuticals (VNDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.